A New Approach for Hypertension: the Case of Sacubitril/Valsartan Experienced in Randomized Controlled Trials That Selectively Restrict Its Use to the Hypertension of the Elderly
Abstract
N/A
J Clin Med Res. 2018;10(11):853-854
doi: https://doi.org/10.14740/jocmr3593w
J Clin Med Res. 2018;10(11):853-854
doi: https://doi.org/10.14740/jocmr3593w